Immunize.org supports evidence-based vaccination recommendations and schedules. Read more at About Us.
  • RSV (Respiratory Syncytial Virus)
  • Vaccine Recommendations for Adults

How do AAFP’s RSV recommendations for the 2026–27 season differ from CDC’s current clinical considerations?

The American Academy of Family Physicians (AAFP) and CDC both recommend one RSV vaccine dose for previously unvaccinated adults age 75 and older and adults age 50–74 at increased risk. Neither routinely recommends adult vaccination below age 50.

AAFP’s current 2026–27 RSV guidance incorporates the American College of Obstetricians and Gynecologists (ACOG) recommendation for a longer window for offering maternal vaccination during pregnancy (September 1–March 1, compared with CDC’s recommended September 1–January 31). AAFP also endorses the American Academy of Pediatrics (AAP) expanded recommendations for the categories of high-risk children eligible for nirsevimab protection before or during their second RSV season. See AAFP’s guidance at www.aafp.org/assets/image/upload/v1791920857/pdf_2026_through_2027_rsv_guidance.pdf. AAFP’s September 2026 adult respiratory immunization guidance is available at  www.aafp.org/assets/image/upload/v1788277985/pdf_2026_through_2027_influenza_rsv_sars_covid_2_guidance.pdf.

Last reviewed: November 8, 2026

This page was updated on .